Robert Labick
Stock Analyst at CJS Securities
(3.42)
# 2,333
Out of 5,014 analysts
9
Total ratings
71.4%
Success rate
29.4%
Average return
Main Sectors:
Stocks Rated by Robert Labick
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACVA ACV Auctions | Downgraded: Hold | n/a | $10.43 | - | 1 | Sep 15, 2026 | |
| NEOG Neogen | Upgraded: Buy | $10 | $12.80 | -21.88% | 2 | Dec 10, 2025 | |
| GFF Griffon | Reiterated: Buy | $29 → $75 | $93.04 | n/a | 2 | May 16, 2022 | |
| OPLN OPENLANE | Upgraded: Buy | $20 | $34.13 | n/a | 1 | May 4, 2022 | |
| BV BrightView Holdings | Initiated Coverage: Buy | $22 | $10.00 | n/a | 1 | Dec 3, 2020 | |
| MODVQ ModivCare Inc. | Upgraded: Buy | $26 → $32 | $0.015 | n/a | 2 | Mar 14, 2014 |
ACV Auctions
Sep 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $10.43
Upside: -
Neogen
Dec 10, 2025
Upgraded: Buy
Price Target: $10
Current: $12.80
Upside: -21.88%
Griffon
May 16, 2022
Reiterated: Buy
Price Target: $29 → $75
Current: $93.04
Upside: n/a
OPENLANE
May 4, 2022
Upgraded: Buy
Price Target: $20
Current: $34.13
Upside: n/a
BrightView Holdings
Dec 3, 2020
Initiated Coverage: Buy
Price Target: $22
Current: $10.00
Upside: n/a
ModivCare Inc.
Mar 14, 2014
Upgraded: Buy
Price Target: $26 → $32
Current: $0.015
Upside: n/a